Source: iQoncept / Shutterstock
Marker Therapeutics (NASDAQ:MRKR) just reported results for the first quarter of 2024.
- Marker Therapeutics reported earnings per share of -27 cents.
- The company reported revenue of $1.24 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/mrkr-stock-earnings-marker-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC